ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+18.17%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$312M
AUM Growth
+$312M
(+20%)
Cap. Flow
-$1.54B
Cap. Flow
% of AUM
-494.76%
Top 10 Holdings %
Top 10 Hldgs %
58.24%
Holding
72
New
22
Increased
15
Reduced
13
Closed
19
Top Buys
| 1 |
Elevance Health
ELV
|
$17M |
| 2 |
Encompass Health
EHC
|
$10.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$10.3M |
| 4 |
SI-BONE Inc
SIBN
|
$10.1M |
| 5 |
Cencora
COR
|
$9.63M |
Top Sells
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$27.7M |
| 2 |
HCA Healthcare
HCA
|
$18M |
| 3 |
Johnson & Johnson
JNJ
|
$13.9M |
| 4 |
Charles River Laboratories
CRL
|
$9.93M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
$8.84M |
Sector Composition
| 1 | Healthcare | 90.71% |
| 2 | Industrials | 1.02% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $25.8M | 8.12% | 401,434 +109,509 | +38% | +$7.03M |
|
|
2
Elevance Health
ELV
$71.8B
| $24.8M | 7.81% | 82,043 +56,386 | +220% | +$17M |
|
3
Zimmer Biomet
ZBH
$21B
| $20.4M | 6.42% | 136,164 -16,332 | -11% | -$2.44M |
|
|
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $20.2M | 6.37% | 1,218,029 +228,593 | +23% | +$3.79M |
|
|
5
Cencora
COR
$56.5B
| $18.6M | 5.86% | 218,820 +113,319 | +107% | +$9.63M |
|
6
Labcorp
LH
$23.1B
| $18.3M | 5.76% | 108,043 +19,060 | +21% | +$3.22M |
|
7
Cigna
CI
$80.3B
| $16.5M | 5.2% | 80,739 +8,630 | +12% | +$1.76M |
|
8
Becton Dickinson
BDX
$55.3B
| $15.5M | 4.89% | 57,131 +35,070 | +159% | +$9.54M |
|
|
9
Encompass Health
EHC
$12.3B
| $11.3M | 3.56% | 163,092 +151,200 | +1,271% | +$10.5M |
|
|
10
Regeneron Pharmaceuticals
REGN
$61.5B
| $10.3M | 3.24% | +27,390 | New | +$10.3M |
|
|
11
SI-BONE Inc
SIBN
$719M
| $10.1M | 3.19% | +470,429 | New | +$10.1M |
|
12
AbbVie
ABBV
$372B
| $8.73M | 2.75% | 98,596 -63,411 | -39% | -$5.61M |
|
13
IQVIA
IQV
$32.4B
| $7.69M | 2.42% | +49,781 | New | +$7.69M |
|
|
HRC
14
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $7.48M | 2.35% | +65,843 | New | +$7.48M |
|
|
PRAH
15
DELISTED
PRA Health Sciences, Inc.
PRAH
| $6.56M | 2.07% | 58,983 -67,826 | -53% | -$7.54M |
|
16
iRhythm Technologies
IRTC
$5.46B
| $6.1M | 1.92% | +89,614 | New | +$6.1M |
|
17
Evolent Health
EVH
$1.12B
| $5.41M | 1.7% | +597,303 | New | +$5.41M |
|
18
Zoetis
ZTS
$69.3B
| $5.32M | 1.68% | 40,197 -20,802 | -34% | -$2.75M |
|
19
Sarepta Therapeutics
SRPT
$1.78B
| $5.14M | 1.62% | +39,822 | New | +$5.14M |
|
20
Iovance Biotherapeutics
IOVA
$807M
| $4.67M | 1.47% | 168,546 +82,477 | +96% | +$2.28M |
|
|
MDRX
21
DELISTED
Veradigm Inc. Common Stock
MDRX
| $4.4M | 1.39% | +447,986 | New | +$4.4M |
|
22
Aclaris Therapeutics
ACRS
$209M
| $3.88M | 1.22% | 2,055,069 +285,284 | +16% | +$539K |
|
|
PRNB
23
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $3.62M | 1.14% | +66,157 | New | +$3.62M |
|
24
Standard BioTools
LAB
$481M
| $3.6M | 1.13% | 1,034,633 +638,932 | +161% | +$2.22M |
|
25
Dentsply Sirona
XRAY
$2.85B
| $3.21M | 1.01% | +56,725 | New | +$3.21M |
|